Joseph Papa

Joseph C.
Papa was the founder of Bionanosim (BNS) Ltd., founded in 2023, serving as Chairman & Chief Executive Officer.
Current jobs include President, Chief Executive Officer & Director at Emergent BioSolutions, Inc. since 2024; Chairman at SparingVision SAS since 2023; Chairman at Beyeonics Surgical Ltd. since 2023; Independent Director at Candel Therapeutics, Inc. since 2022; Independent Non-Executive Director at Milestone Pharmaceuticals, Inc. since 2024; and Executive Advisor at Water Street Healthcare Partners LLC since 2023.
Former jobs include Chairman & Chief Executive Officer at Bausch & Lomb, Inc.; Chairman, CEO-Pharmaceutical & Technologies at Cardinal Health, Inc. from 2004 to 2006; Chairman, President & Chief Executive Officer at Perrigo Co. and Perrigo Co. Plc from 2007 to 2016; Chief Executive Officer at Bausch & Lomb Holdings, Inc.; Chief Executive Officer & Director at Bausch + Lomb Corp.
from 2022 to 2023; Independent Non-Executive Director at Smith & Nephew plc from 2008 to 2018; Director at The University of Connecticut Foundation, Inc.; Director at Bausch Health Cos., Inc. in 2022; Independent Non-Executive Director at Smith & Nephew A; Lead Independent Director at Prometheus Biosciences, Inc. from 2021 to 2023; Director at The Cooper Cos., Inc.; President & Chief Operating Officer at Actavis, Inc. from 2001 to 2004; Vice President-Marketing at Novartis International AG; Principal at Novartis AG; President & Chief Operating Officer at DuPont Pharmaceuticals Co. in 2001; President at G.D.
Searle & Co., Inc. from 1997 to 2000; President-North American Global Country Operations at Pharmacia Corp.
from 2000 to 2001; President at Perrigo Florida, Inc. (Florida); President & Chief Operating Officer at Actavis Pharma, Inc.; and President at Sergeant's Pet Care Products, Inc. Education includes an undergraduate degree from the University of Connecticut in 1978 and an MBA from Kellogg School of Management.